Literature DB >> 10807732

Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury.

M B Wright1, R A Seifert, D F Bowen-Pope.   

Abstract

Many protein-tyrosine phosphatases (PTPases) have now been identified, but little is known about PTPase expression and regulation in vascular tissue and in vascular disease. Polymerase chain reaction (PCR) amplification and cDNA fingerprinting of PTPase catalytic domains, combined with random sequencing of PCR product libraries, identified 18 (8 receptor-like and 10 cytosolic) PTPases in the rat carotid artery and revealed differential expression of 5 of these PTPases during neointima formation after balloon catheter injury. In situ hybridization was used to localize mRNA expression in vessel cross sections for the 5 differentially expressed PTPases. This revealed that for 3 PTPases (SHP1, CD45, and PTPbeta), differential transcript abundance was due to appearance/loss of the cell types by which they were expressed (leukocytes for SHP1 and CD45, endothelial cells for PTPbeta). However, mRNA expression of 2 PTPases (PTPL1 and PTP1B) was specifically upregulated by proliferating and migrating smooth muscle cells (SMCs) in characteristic temporal and regional patterns in response to vessel damage. Quantitative PCR analysis showed that PTP1B and PTPL1 were induced approximately 30-fold and approximately 60-fold, respectively, by 2 weeks after injury in the damaged vessels compared with the uninjured vessels. PTP1B was rapidly upregulated in the media after vessel injury and remained highly expressed in the developing neointima. By contrast, PTPL1 expression did not increase dramatically until the SMCs had migrated into the intima. The differential expression of PTP1B and PTPL1 by SMCs after injury suggests roles for these PTPases in the regulation of vessel wall remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807732     DOI: 10.1161/01.atv.20.5.1189

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

Review 1.  Modulation of VEGF receptor 2 signaling by protein phosphatases.

Authors:  Federico Corti; Michael Simons
Journal:  Pharmacol Res       Date:  2016-11-23       Impact factor: 7.658

2.  Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of Protein Tyrosine Phosphatase-1B.

Authors:  Pimonrat Ketsawatsomkron; David W Stepp; David J Fulton; Mario B Marrero
Journal:  Vascul Pharmacol       Date:  2010-06-25       Impact factor: 5.773

3.  Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling.

Authors:  Toshiyuki Fukada; Nicholas K Tonks
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

4.  Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery.

Authors:  Qinghua Pu; Yingzi Chang; Chunxiang Zhang; Yi Cai; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

5.  Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.

Authors:  Li-Fan Zeng; Ruo-Yu Zhang; Yunpeng Bai; Li Wu; Andrea M Gunawan; Zhong-Yin Zhang
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

6.  Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.

Authors:  David J Herren; David J Herre; J Blake Norman; Ruchi Anderson; Michel L Tremblay; Anne-Cecile Huby; Eric J Belin de Chantemèle
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury.

Authors:  Rajinikanth Gogiraju; Sogol Gachkar; David Velmeden; Magdalena L Bochenek; Konstantinos Zifkos; Astrid Hubert; Thomas Münzel; Stefan Offermanns; Katrin Schäfer
Journal:  Thromb Haemost       Date:  2022-09-08       Impact factor: 6.681

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.